J Am Dent Assoc
December 2024
Background: The authors reviewed a case involving the orofacial manifestations of Crohn disease (CD) in an adolescent whose treatment was ultimately managed with a newer class of biologic drug agent, ustekinumab (Stelara, Janssen Biotech). CD is a chronic inflammatory condition affecting the gastrointestinal tract that often causes extraintestinal complications. The underlying etiology of CD involves genetic, environmental, and local factors.
View Article and Find Full Text PDFJ Dent Child (Chic)
November 2023
Full-coverage restorations are indicated for posterior primary teeth as definitive treatments for high caries-risk children and in patients whose treatment is being performed under general anesthesia. Advances in biomaterials and parental preferences have driven interest in esthetic full coverage treatment options for primary posterior teeth. The prefabricated resin crown offers a 'flex fit' adaptation over the anatomic cervical convexity of the primary clinical crown, similar in functionality to a stainless steel crown.
View Article and Find Full Text PDFPurpose: The purpose of this retrospective study was to assess how procedural code trends reflect the adoption of evidence-based best-clinical-practice guidelines in a hospital-based pediatric dental residency program.
Methods: Data on frequency of indirect pulp therapy (IPT) and primary pulpotomy (P) utilization were assessed from 2008 to 2020.
Results: The rate of procedural change between IPT and P significantly differed (P<0.
The purpose of this descriptive study was to describe oral manifestations and oral health quality of life (QOL) in children aged six months to six years, 11 months with tuberous sclerosis complex (TSC). Parents of participants completed an oral health QOL survey. The presence of oral lesions associated with TSC was assessed.
View Article and Find Full Text PDF